4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0000950170-25-080311
Director sold 2,783 shares at $7.35 ($20,465)
- Director acquired 4,800 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jenkins John Kenneth · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-30 | Sale : show line 1 in the form 10b5-1 | −2,783 | $7.35 | $20,465 | 33 | D |
| 2025-05-30 | Grant or award : show line 2 in the form 10b5-1 | +4,800 | 4,833 | D | ||
| Open-market sales · 2,783 sh · avg $7.35 · $20,465 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-30 | Grant or award : show line 3 in the form 10b5-1 Stock options (right to buy) | +16,000 | 16,000 | D |
Loading xslF345X05/ownership.xml…